Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CANN GROUP LIMITED Regulatory Filings 2021

Feb 7, 2021

64603_rns_2021-02-07_b8f047a0-9d7a-446c-a2c2-ea2970f30694.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [585 x 60] intentionally omitted <==

ASX ANNOUNCEMENT

8 February 2021

Cann Group advises of cyber security incident

8 February 2021 – Cann Group Limited (ASX: CAN) ( Cann or the Company ) advises that it has experienced a cyber security incident, involving an unknown third party. The breach was discovered overnight on 4 February 2021 and is currently under investigation.

The Company has recently made payments of approximately A$3.6 million to an overseas contractor (in relation to works being undertaken for Cann’s Mildura facility), however those payments have been received by an unknown third party as a result of a complex and sophisticated cyber fraud perpetrated against the Company and its overseas contractor. The Company is working with its bank to determine if any of the payments can be halted and if any of the funds involved are recoverable. The Company has notified its insurance brokers to determine if a claim can be made to recover any of the losses involved. Immediate action has also been taken to ensure the integrity of Cann’s IT systems.

The Company is in a financial position to continue with its ongoing operations and projects, including the construction of its Mildura facility, irrespective of any funds being recovered.

The Company and its overseas contractor are investigating the incident thoroughly, including the engagement of external security and forensic IT experts to assist. The matter has been reported to police in Victoria, Australia, the Netherlands and Hong Kong, as well as the Office of Drug Control. Further updates will be provided in due course as the investigation proceeds.

Authorised for release by the Board, Cann Group Limited.

For all media enquiries please contact:

Matthew Wright NWR Communications +61 451 896 420 [email protected]

For all other information please contact:

Peter Crock Clive Fanning CEO Head of Investor Relations Cann Group Limited Cann Group Limited +61 3 9095 7088 +61 3 9095 7088 [email protected] [email protected]

About Cann Group

Cann Group Limited (ABN 25 603 949 739) is building a world-class business focused on breeding, cultivating, manufacturing and supplying medicinal cannabis for sale and use within Australia and for approved overseas export markets. The company has established research and cultivation facilities in Melbourne and is developing a state-of-the-art cultivation facility near Mildura, Victoria. Cann Group has executed collaboration agreements that have enabled it to establish a leading position in plant genetics, breeding, extraction, analysis and production techniques required to facilitate the supply of medicinal cannabis for a range of diseases and medical conditions. The Company is commercialising a range of imported and locally sourced and manufactured medicinal cannabis products. Learn more about Cann Group at www.canngrouplimited.com

Cann Group Limited ACN 603 949 739 4 Research Avenue, Bundoora, VIC 3083 Australia Ph: +61 3 9095 7088